Divamics Unveils Advanced Autoimmune Treatment DVI-001 at JPM Week 2026 Divamics showcased its leading autoimmune program DVI-001 and introduced the new metabolic program DVI-004 at JPM Week 2026, emphasizing AI's role in biotech.

Divamics Unveils Advanced Autoimmune Treatment DVI-001 at JPM Week 2026 #United_States #San_Francisco #biotechnology #Divamics #DVI-001

How Divamics' AI Platform is Revolutionizing Drug Discovery for Metabolic Diseases Divamics is making waves in drug discovery for metabolic diseases by leveraging AI and molecular dynamics for groundbreaking therapeutic advancements.

How Divamics' AI Platform is Revolutionizing Drug Discovery for Metabolic Diseases #China #Suzhou #AI_Platform #BGM1812 #Divamics